🔴 Lantern Pharma is trading 12.31% down in pre-market after announcing a $4 million registered direct offering

Lantern Pharma is trading at $0.96, down 12.31%, after announcing a registered direct offering.

• On September 29, 2026, it announced 3,669,725 shares or pre-funded warrants at $1.09 each, expected to raise about $4 million before expenses.
• Private-placement warrants could yield approximately $4 million more if exercised; proceeds are intended for working capital and general corporate purposes.
• Closing is expected on or about September 30, subject to customary conditions; the offering introduces potential dilution. Shares closed at $1.09 September 28; broader-market context showed no comparable pre-market decline.